SGLTS/DPP4 INHIBITOR AND APPLICATION THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20220259247A1
SERIAL NO

17629618

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A class of compounds as a SGLT1/SGLT2/DPP4 triple inhibitor, and an application in preparation of a drug serving as the SGLT1/SGLT2/DPP4 triple inhibitor. Compounds represented by formula (I), and isomers and pharmaceutically-acceptable salts thereof are specifically involved.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO LTDHANGZHOU ZHEJIANG 310018

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CHEN, Shuhui Shanghai, CN 339 290
LI, Yi Shanghai, CN 917 5421
MAO, Qinghua Shanghai, CN 13 7
WU, Chengde Shanghai, CN 81 1161
YU, Tao Shanghai, CN 278 2223

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation